Publicacións (97) Publicacións de Alfonso Vidal Casariego

2024

  1. Adherence and impact of an oral nutritional supplement enriched in leucine, EVOO, EPA and DHA, and beta-glucans on the coverage of energy and protein requirements in patients with cancer and malnutrition: Alisenoc study

    Nutrition, Vol. 120

2023

  1. GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 1, pp. 29-38

  2. Impact of an oral nutritional supplement enriched in leucine, EPA, DHA, and β-glucans on the increase of muscle mass in patients with cancer and malnutrition: The alisenoc trial

    Journal of Functional Foods, Vol. 110

2022

  1. Aetiological diagnosis of hyponatraemia in non-critical patients on total parenteral nutrition: A prospective multicentre study

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 3, pp. 160-167

  2. Process of medical nutrition therapy

    Nutricion Hospitalaria, Vol. 39, Núm. 5, pp. 1166-1189

2021

  1. Acceptance of different types of thickeners, with and without flavoring, in hospitalized patients with dysphagia — a pilot study

    Nutricion Hospitalaria, Vol. 38, Núm. 5, pp. 1082-1088

  2. Analysis of hospitalizations in the population with diabetes with EHRead tools

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 6, pp. 444-446

  3. Comparison of MUST and Nutriscore for the Screening of Malnutrition in Hospitalized Oncology Patients

    Nutrition and Cancer, Vol. 73, Núm. 10, pp. 1941-1946

  4. Covid pandemic and clinical nutrition response in spain: Results of a national survey

    Nutricion Hospitalaria, Vol. 38, Núm. 1, pp. 207-212

  5. Estándares del proceso de soporte nutricional en España: hacia el “benchmarking”

    Nutricion hospitalaria, Vol. 38, Núm. 3, pp. 661-666

2020

  1. Clinical experience with tolvaptan outpatient use. Cost and effectiveness in 9 cases

    Gaceta Medica de Mexico, Vol. 156, Núm. 1, pp. 76-79

  2. Experiencia clínica con el uso ambulatorio de tolvaptan. Costes y efectividad en nueve casos

    Gaceta medica de Mexico, Vol. 156, Núm. 1, pp. 78-81

  3. Postoperative enteral immunonutrition in head and neck cancer patients: Impact on clinical outcomes

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 1, pp. 13-19

  4. Utility of the eat-10 in the detection of dysphagia in high-risk hospitalisation units at a university hospital: A cross-sectional study

    Nutricion Hospitalaria, Vol. 37, Núm. 6, pp. 1197-1200

2019

  1. Clinical experience with different initial doses of tolvaptan in SIADH

    Nefrologia

  2. The appearance of malnutrition in hematological inpatients prolongs hospital stay: The need for nutritional surveillance during hospitalization

    Nutricion Hospitalaria, Vol. 36, Núm. 2, pp. 372-378

  3. Valoración del riesgo de malnutrición en pacientes institucionalizados en función del grado de dependencia

    Nutricion hospitalaria, Vol. 36, Núm. 2, pp. 296-302

2018

  1. Epidemiology of home enteral nutrition: An approximation to reality

    Nutricion Hospitalaria, Vol. 35, Núm. 3, pp. 511-518

2017

  1. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice

    Reumatologia Clinica, Vol. 13, Núm. 5, pp. 258-263

  2. Appetite disorders in cancer patients: Impact on nutritional status and quality of life

    Appetite, Vol. 114, pp. 23-27